An Act To Require Health Insurance Coverage For Biomarker Testing
Died in Possession of the Senate when the Legislature adjourned Sine Die and was PLACED IN THE LEGISLATIVE FILES. (DEAD)
Summary
The bill would make it mandatory for MaineCare and private health plans to pay for biomarker tests—such as gene or protein analyses—if the test is supported by FDA labeling, Medicare coverage decisions, or recognized clinical guidelines. It applies to individual, group, and Medicaid‑type policies and sets timelines for prior‑authorization decisions. The measure failed to pass before the legislature adjourned.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when LD 107 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track LD 107 freeOr ask your AI assistant about LD 107 directly:
Add to Claude, ChatGPT or Cursor